Data Analysis and Performance Assessment

As results are in the form of discreet interpretations, the majority view (>80%) of the presence or absence of a genetic mutation can be taken as the correct value. Centres reporting a different interpretation for any one of the three samples are therefore deemed "unsatisfactory" and a letter is sent from the Scheme Director.

More than one unsatisfactory performance in any fifteen consecutive surveys (i.e. a 5 year period) will be designated as persistent unsatisfactory performance.

Print Print | Sitemap

UK NEQAS for Blood Coagulation programmes are hosted by the Sheffield Teaching Hospitals NHS Foundation Trust. We are a UKAS accredited proficiency testing provider (BS EN ISO/IEC 17043:2010).
Terms and Conditions
Privacy Policy

Participant Login
Facebook
Twitter

© UK NEQAS FOR BLOOD COAGULATION

Call

E-mail

Directions